Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CA 72-4' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 45 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gaspar, MJ; Arribas, I; Coca, MC; Diez-Alonso, M
      Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma

      TUMOR BIOLOGY
    2. Vitores, AMG; Duro, GE; Fraile, BB; Carrasco, MA
      Prognostic value of the glycoprotein TAG-72 in patients with gastric cancer

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    3. Tas, F; Aykan, F; Aydiner, A; Yasasever, V; Topuz, E
      Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    4. Marrelli, D; Pinto, E; De Stefano, A; De Manzoni, G; Farnetani, M; Garosi, L; Roviello, F
      Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer

      JOURNAL OF SURGICAL ONCOLOGY
    5. Duraker, N; Celik, AN
      The prognostic significance of preoperative sevum CA 19-9 in patients withresectable gastric carcinoma: Comparison with CEA

      JOURNAL OF SURGICAL ONCOLOGY
    6. Marrelli, D; Pinto, E; De Stefano, A; Farnetani, M; Garosi, L; Roviello, F
      Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patientswith resectable gastric cancer

      AMERICAN JOURNAL OF SURGERY
    7. Allende, MT; Vizoso, F; Suarez, C; Garcia, I; Sanz, L; Garcia-Muniz, JL; Roiz, C
      TAG-72 in gastric cancer: relationship between preoperative serum levels and tumoral content of the antigen

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    8. Filella, X; Friese, S; Roth, HJ; Nussbaum, S; Wehnl, B
      Technical performance of the Elecsys (R) CA 72-4 test - Development and field study

      ANTICANCER RESEARCH
    9. Holubec, L; Topolcan, O; Pikner, R; Pecen, L; Vaclavickova, J; Wirthova, M; Molacek, J; Stieber, P; Holdenrieder, S; Sen, LH; Finek, J
      The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence

      ANTICANCER RESEARCH
    10. Hammel, P
      Diagnostic value of cyst fluid analysis in the cystic lesions of the pancreas: overview, limits and outlook

      JOURNAL DE RADIOLOGIE
    11. Bohner, H; Zimmer, T; Hopfenmuller, W; Berger, G; Buhr, HJ
      Detection and prognosis of recurrent gastric cancer-is routine follow-up after gastrectomy worthwhile?

      HEPATO-GASTROENTEROLOGY
    12. Bujan, P; Morell, R; Gonzalez, A
      Gastric carcinoma: expression of c-erbB-2/neu oncoprotein, epidermal growth factor receptor, cathepsin D, progesterone receptor and tumor associated glycoprotein-72 in different histological types

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    13. Gaudagni, F
      The clinical utility of serum tumor markers in the management of gastrointestinal cancer patients

      JOURNAL OF CLINICAL LIGAND ASSAY
    14. Imada, T; Rino, Y; Takahashi, M; Hatori, S; Shiozawa, M; Amano, T; Kondo, J
      Serum CA 19-9, SLX, STN and CEA levels of the peripheral and the draining venous blood in gastric cancer

      HEPATO-GASTROENTEROLOGY
    15. Marrelli, D; Roviello, F; De Stefano, A; Farnetani, M; Garosi, L; Messano, A; Pinto, E
      Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma

      ONCOLOGY
    16. Ferrer, J; Villarino, MA; Encabo, G; Felip, E; Bermejo, B; Vila, S; Orriols, R
      Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuronspecific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions

      CANCER
    17. LOOK M; TEH CH; YEONG WS; GN C; LOW CH
      COMBINED USE OF CEA, CA-19-9 AND AFP FOR THE PREOPERATIVE PREDICTION OF STAGE-IV GASTRIC-CANCER

      GI cancer (Print)
    18. Nakajima, K; Ochiai, T; Suzuki, T; Shimada, H; Hayashi, H; Yasumoto, A; Takeda, A; Hishikawa, E; Isono, K
      Impact of preoperative serum carcinoembryonic antigen, CA 19-9 and alpha fetoprotein levels in gastric cancer patients

      TUMOR BIOLOGY
    19. HAMMEL P; VOITOT H; VILGRAIN V; LEVY P; RUSZNIEWSKI P; BERNADES P
      DIAGNOSTIC-VALUE OF CA-72-4 AND CARCINOEMBRYONIC ANTIGEN DETERMINATION IN THE FLUID OF PANCREATIC CYSTIC LESIONS

      European journal of gastroenterology & hepatology
    20. Tayyar, M; Tutus, A
      Measurement of CA 72.4 in maternal serum and amniotic fluid

      JOURNAL OF PERINATAL MEDICINE
    21. TOCCHI A; COSTA G; LEPRE L; LIOTTA G; MAZZONI G; CIANETTI A; VANNINI P
      THE ROLE OF SERUM AND GASTRIC-JUICE LEVELS OF CARCINOEMBRYONIC ANTIGEN, CA19.9 AND CA72.4 IN PATIENTS WITH GASTRIC-CANCER

      Journal of cancer research and clinical oncology
    22. SCHUTTER EMJ; SOHN C; KRISTEN P; MOBUS V; CROMBACH G; KAUFMANN M; CAFFIER H; KREIENBERG R; VERSTRAETEN AA; KENEMANS P
      ESTIMATION OF PROBABILITY OF MALIGNANCY USING A LOGISTIC MODEL COMBINING PHYSICAL-EXAMINATION, ULTRASOUND, SERUM CA-125, AND SERUM CA-72-4 IN POSTMENOPAUSAL WOMEN WITH A PELVIC MASS - AN INTERNATIONAL MULTICENTER STUDY

      Gynecologic oncology
    23. Fernandez-Llamazares, J; Pinol, M; Encabo, G; Gelonch, J
      Tumor markers in gastric cancer. The TAG-72 is the most useful

      MEDICINA CLINICA
    24. SALAMA G; MIEDOUGE M; ROUZAUD P; MAUDUYT MA; PUJAZON MC; VINCENT C; CARLES P; SERRE G
      EVALUATION OF PLEURAL CYFRA-21-1 AND CARCINOEMBRYONIC ANTIGEN IN THE DIAGNOSIS OF MALIGNANT PLEURAL EFFUSIONS

      British Journal of Cancer
    25. GARTNER U; SCHEULEN ME; CONRADT C; WIEFELSPUTZ J; KRUCK P; AGHABI E; DELBRUCK H
      VALUE OF TUMOR-ASSOCIATED ANTIGEN CA-72-4 COMPARED WITH CEA AND CA-19-9 IN THE FOLLOW-UP OF PATIENTS OPERATED FOR GASTRIC-CARCINOMA

      Deutsche Medizinische Wochenschrift
    26. IMADA T; RINO Y; TAKAHASHI M; HATORI S; SHIOZAWA M; TANAKA J; YAMAMOTO Y; AMANO T; KONDO J
      EXPRESSION OF CA19-9, SLX, STN AND CEA IN RELATIVELY EARLY GASTRIC-CARCINOMA

      Oncology Reports
    27. REITER W; STIEBER P; REUTER C; NAGEL D; CRAMER C; PAHL H; FATEHMOGHADAM A
      PROGNOSTIC VALUE OF PREOPERATIVE SERUM LEVELS OF CEA CA-19-9 AND CA-72-4 IN GASTRIC-CARCINOMA

      Anticancer research
    28. GUADAGNI F; ROSELLI M; COSIMELLI M; FERRONI P; SPILA A; CAVALIERE F; ARCURI R; CARLINI S; MARIOTTI S; GANDOLFO GM; CASCIANI CU; GREINER JW; SCHLOM J
      TAG-72 EXPRESSION AND ITS ROLE IN THE BIOLOGICAL EVALUATION OF HUMAN COLORECTAL-CANCER

      Anticancer research
    29. SPILA A; ROSELLI M; COSIMELLI M; FERRONI P; CAVALIERE F; ARCURI R; TEDESCO M; CARLINI S; DALESSANDRO R; PERRI P; CASCIANI CU; GREINER JW; SCHLOM J; GUADAGNI F
      CLINICAL UTILITY OF CA-72-4 SERUM MARKER IN THE STAGING AND IMMEDIATEPOSTSURGICAL MANAGEMENT OF GASTRIC-CANCER PATIENTS

      Anticancer research
    30. PLEBANI M; DEPAOLI M; BASSO D; ROVERONI G; GIACOMINI A; GALEOTTI F; CORSINI A
      SERUM TUMOR-MARKERS IN COLORECTAL-CANCER STAGING, GRADING, AND FOLLOW-UP

      Journal of surgical oncology
    31. HASHOLZNER U; BAUMGARTNER L; STIEBER P; MEIER W; REITER W; PAHL H; FATEHMOGHADAM A
      CLINICAL-SIGNIFICANCE OF THE TUMOR-MARKERS CA-125-II AND CA-72-4 IN OVARIAN-CARCINOMA

      International journal of cancer
    32. HEINZE T; GREINERMAI E
      IMMUNOLUMINOMETRIC ASSAY FOR DETERMINING CA-72-4 IN PATIENTS WITH GYNECOLOGICAL TUMORS

      Clinical chemistry
    33. VILLENA V; LOPEZENCUENTRA A; ECHAVESUSTAETA J; MARTINESCRIBANO P; ORTUNODESOLO B; ESTENOZALFARO J
      DIAGNOSTIC-VALUE OF CA-72-4, CARCINOEMBRYONIC ANTIGEN, GA-15-3, AND CA-19-9 ASSAY IN PLEURAL FLUID - A STUDY OF 207 PATIENTS

      Cancer
    34. SPERTI C; PASQUALI C; GUOLO P; POLVEROSI R; LIESSI G; PEDRAZZOLI S
      SERUM TUMOR-MARKERS AND CYST FLUID ANALYSIS ARE USEFUL FOR THE DIAGNOSIS OF PANCREATIC CYSTIC TUMORS

      Cancer
    35. GUADAGNI F; ROSELLI M; COSIMELLI M; FERRONI P; SPILA A; CAVALIERE F; CASALDI V; WAPPNER G; ABBOLITO MR; GREINER JW; SCHLOM J
      CA-72-4 SERUM MARKER - A NEW TOOL IN THE MANAGEMENT OF CARCINOMA PATIENTS

      Cancer investigation
    36. REITER W; STIEBER P; REUTER C; NAGEL D; CRAMER C; FATEHMOGHADAM A
      SENSITIVITY AND PROGNOSTIC-SIGNIFICANCE OF CA-72-4, CEA, AND CA-19-9 SERUM LEVELS IN UNTREATED PATIENTS WITH GASTRIC-CANCER

      Tumordiagnostik & Therapie
    37. WANG JY; BRUNNER CJ; GANGOPADHYAY A; BIRD AC; WOLFE LG
      DETECTION OF TUMOR-ASSOCIATED ANTIGENS IN SERA OF CANINE CANCER-PATIENTS BY MONOCLONAL-ANTIBODIES GENERATED AGAINST CANINE MAMMARY-CARCINOMA CELLS

      Veterinary immunology and immunopathology
    38. JOYPAUL B; BROWNING M; NEWMAN E; BYRNE D; CUSCHIERI A
      COMPARISON OF SERUM CA-72-4 AND CA-19-9 LEVELS IN GASTRIC-CANCER PATIENTS AND CORRELATION WITH RECURRENCE

      The American journal of surgery
    39. FILELLA X; FUSTER J; MOLINA R; GRAU JJ; GARCIAVALDECASAS JC; GRANDE L; ESTAPE J; BALLESTA AM
      TAG-72, CA-19.9 AND CEA AS TUMOR-MARKERS IN GASTRIC-CANCER

      Acta oncologica
    40. HASHOLZNER U; BAUMGARTNER L; STIEBER P; MEIER W; HOFMANN K; FATEHMOGHADAM A
      SIGNIFICANCE OF THE TUMOR-MARKERS CA-125-II, CA-72-4, CASA AND CYFRA-21-1 IN OVARIAN-CARCINOMA

      Anticancer research
    41. WERTHER JL; RIVERAMACMURRAY S; BRUCKNER H; TATEMATSU M; ITZKOWITZ SH
      MUCIN-ASSOCIATED SIALOSYL-TN ANTIGEN EXPRESSION IN GASTRIC-CANCER CORRELATES WITH AN ADVERSE OUTCOME

      British Journal of Cancer
    42. WOOLAS R; XU FJ; DALY L; SOPER JT; BERCHUCK A; RODRIGUEZ G; CLARKEPEARSON DL; BOYER CM; BAST RC
      SCREENING STRATEGIES FOR OVARIAN-CANCER

      Diagnostic oncology
    43. SCHLEICH HG; HOFMANN I; WISCHNIK A; HETTENBACH A; HEINE M; SCHMIDT R; MELCHERT F
      ON THE VALIDITY OF SIMULTANEOUS DETERMINATIONS OF CA-125, SRA, AND CA-72-4 IN PATIENTS SUFFERING FROM OVARIAN-TUMORS

      Onkologie
    44. GUADAGNI F; ROSELLI M; COSIMELLI M; FERRONI P; SPILA A; CASALDI V; CAVALIERE F; CARLINI M; GAROFALO A; RINALDI G; SANTORO E; GREINER JW; SCHLOM J
      CORRELATION BETWEEN POSITIVE CA-72-4 SERUM LEVELS AND LYMPH-NODE INVOLVEMENT IN PATIENTS WITH GASTRIC-CARCINOMA

      Anticancer research
    45. GUADAGNI F; ROSELLI M; COSIMELLI M; MANNELLA E; TEDESCO M; CAVALIERE F; GRASSI A; ABBOLITO MR; GREINER JW; SCHLOM J
      TAG-72 (CA 72-4 ASSAY) AS A COMPLEMENTARY SERUM TUMOR-ANTIGEN TO CARCINOEMBRYONIC ANTIGEN IN MONITORING PATIENTS WITH COLORECTAL-CANCER

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 23:14:48